Exertional Dyspnoea in COPD: the Clinical Utility of Cardiopulmonary Exercise Testing
Overview
Authors
Affiliations
Activity-related dyspnoea is often the most distressing symptom experienced by patients with chronic obstructive pulmonary disease (COPD) and can persist despite comprehensive medical management. It is now clear that dyspnoea during physical activity occurs across the spectrum of disease severity, even in those with mild airway obstruction. Our understanding of the nature and source of dyspnoea is incomplete, but current aetiological concepts emphasise the importance of increased central neural drive to breathe in the setting of a reduced ability of the respiratory system to appropriately respond. Since dyspnoea is provoked or aggravated by physical activity, its concurrent measurement during standardised laboratory exercise testing is clearly important. Combining measurement of perceptual and physiological responses during exercise can provide valuable insights into symptom severity and its pathophysiological underpinnings. This review summarises the abnormal physiological responses to exercise in COPD, as these form the basis for modern constructs of the neurobiology of exertional dyspnoea. The main objectives are: 1) to examine the role of cardiopulmonary exercise testing (CPET) in uncovering the physiological mechanisms of exertional dyspnoea in patients with mild-to-moderate COPD; 2) to examine the escalating negative sensory consequences of progressive respiratory impairment with disease advancement; and 3) to build a physiological rationale for individualised treatment optimisation based on CPET.
Staes M, Gyselinck I, Goetschalckx K, Troosters T, Janssens W Eur Respir Rev. 2024; 33(173).
PMID: 39231595 PMC: 11372471. DOI: 10.1183/16000617.0010-2024.
Deng Z, Wu F, Wan Q, Dai C, Lu L, Peng J BMJ Open Respir Res. 2024; 11(1).
PMID: 39032939 PMC: 11261676. DOI: 10.1136/bmjresp-2024-002320.
de Campos G, Goelzer L, Augusto T, Barbosa G, Chiappa G, Van Iterson E Arq Bras Cardiol. 2024; 121(4):e20230578.
PMID: 38695473 PMC: 11164473. DOI: 10.36660/abc.20230578.
Kandels J, Stobe S, Kogel A, Hepp P, Riepenhof H, Droste J Echo Res Pract. 2023; 10(1):17.
PMID: 37789500 PMC: 10548575. DOI: 10.1186/s44156-023-00029-6.
Laboratory and free-living gait performance in adults with COPD and healthy controls.
Buekers J, Megaritis D, Koch S, Alcock L, Ammour N, Becker C ERJ Open Res. 2023; 9(5).
PMID: 37753279 PMC: 10518872. DOI: 10.1183/23120541.00159-2023.